Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-03

Clinical Trial Update: Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients

View source ↗

Summary

Clinical trial update evaluating urinary beta-2 microglobulin as an early marker of renal dysfunction in Vietnamese patients with HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Center for Global Health and Medicine, Japan | Conditions: HIV Infection, Renal Function Disorder | Status: UNKNOWN